In vitro, RT increases LOX secretion in a dose-dependent manner in several tumor cell types (lung adenocarcinoma, colon carcinoma, glioma, vulva cancer, breast adenocarcinoma), which in turn promotes cancer cell invasion. Here, LOX is linked to neoplasm.